View in EDS

Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma.

Saved in:
Bibliographic Details
Title: Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma.
Authors: Gomes-da-Silva NC; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil., Cavalcanti A; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Alves G; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Meohas W; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Facchetti B; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil., Perini JA; Research Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil., Rebelo Alencar LM; Federal University of Maranhão, Department of Physics, Biophysics Laboratory, Campus Bacanga, São Luís, MA 65080-805, Brazil., Ricci-Junior E; LADEG, Laboratory of Pharmaceutical Nanotechnology, Faculty of Pharmacy, DEFARMED, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil., Fechine PBA; Group of Chemistry of Advanced Materials (GQMat), Department of Analytical Chemistry and Physical-Chemistry, Federal University of Ceará, Fortaleza, CE 451-970, Brazil., Barja-Fidalgo TC; Laboratory of Cellular & Molecular Pharmacology, Department of Cell Biology, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551030, RJ, Brazil., Rosas EC; Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil., Santos-Oliveira R; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil; State University of Rio de Janeiro, Laboratory of Nanoradiopharmacy and Strategic Biomaterials, Rio de Janeiro, RJ 220000, Brazil. Electronic address: roliveira@ien.gov.br.
Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2026 Sep; Vol. 226, pp. 115132. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42242509
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lipoxin A4 (LXA<subscript>4</subscript>) versus Nanolipoxin A4 (Nano-LXA<subscript>4</subscript>) for osteosarcoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gomes-da-Silva+NC%22">Gomes-da-Silva NC</searchLink>; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil.<br /><searchLink fieldCode="AU" term="%22Cavalcanti+A%22">Cavalcanti A</searchLink>; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil.<br /><searchLink fieldCode="AU" term="%22Alves+G%22">Alves G</searchLink>; Unidade de Pesquisa Experimental em Ortopedia, Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil.<br /><searchLink fieldCode="AU" term="%22Meohas+W%22">Meohas W</searchLink>; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil.<br /><searchLink fieldCode="AU" term="%22Facchetti+B%22">Facchetti B</searchLink>; Centro de Atenção Especializada em Oncologia Ortopédica Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro 20940070, Brazil.<br /><searchLink fieldCode="AU" term="%22Perini+JA%22">Perini JA</searchLink>; Research Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department (DepFarm), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil.<br /><searchLink fieldCode="AU" term="%22Rebelo+Alencar+LM%22">Rebelo Alencar LM</searchLink>; Federal University of Maranhão, Department of Physics, Biophysics Laboratory, Campus Bacanga, São Luís, MA 65080-805, Brazil.<br /><searchLink fieldCode="AU" term="%22Ricci-Junior+E%22">Ricci-Junior E</searchLink>; LADEG, Laboratory of Pharmaceutical Nanotechnology, Faculty of Pharmacy, DEFARMED, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Fechine+PBA%22">Fechine PBA</searchLink>; Group of Chemistry of Advanced Materials (GQMat), Department of Analytical Chemistry and Physical-Chemistry, Federal University of Ceará, Fortaleza, CE 451-970, Brazil.<br /><searchLink fieldCode="AU" term="%22Barja-Fidalgo+TC%22">Barja-Fidalgo TC</searchLink>; Laboratory of Cellular & Molecular Pharmacology, Department of Cell Biology, Instituto de Biologia Roberto Alcantara Gomes (IBRAG), Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20551030, RJ, Brazil.<br /><searchLink fieldCode="AU" term="%22Rosas+EC%22">Rosas EC</searchLink>; Laboratory of Applied Pharmacology, Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.<br /><searchLink fieldCode="AU" term="%22Santos-Oliveira+R%22">Santos-Oliveira R</searchLink>; Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmacy and Synthesis of New Radiopharmaceuticals, Rio de Janeiro, RJ 21941906, Brazil; State University of Rio de Janeiro, Laboratory of Nanoradiopharmacy and Strategic Biomaterials, Rio de Janeiro, RJ 220000, Brazil. Electronic address: roliveira@ien.gov.br.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229109778%22">European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</searchLink> [Eur J Pharm Biopharm] 2026 Sep; Vol. 226, pp. 115132. <i>Date of Electronic Publication: </i>2026 Jun 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9109778 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3441 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209396411%22">09396411 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Pharm Biopharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42242509
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejpb.2026.115132
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115132
    Titles:
      – TitleFull: Lipoxin A4 (LXA4) versus Nanolipoxin A4 (Nano-LXA4) for osteosarcoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gomes-da-Silva NC
      – PersonEntity:
          Name:
            NameFull: Cavalcanti A
      – PersonEntity:
          Name:
            NameFull: Alves G
      – PersonEntity:
          Name:
            NameFull: Meohas W
      – PersonEntity:
          Name:
            NameFull: Facchetti B
      – PersonEntity:
          Name:
            NameFull: Perini JA
      – PersonEntity:
          Name:
            NameFull: Rebelo Alencar LM
      – PersonEntity:
          Name:
            NameFull: Ricci-Junior E
      – PersonEntity:
          Name:
            NameFull: Fechine PBA
      – PersonEntity:
          Name:
            NameFull: Barja-Fidalgo TC
      – PersonEntity:
          Name:
            NameFull: Rosas EC
      – PersonEntity:
          Name:
            NameFull: Santos-Oliveira R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2026 Sep
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-3441
          Numbering:
            – Type: volume
              Value: 226
          Titles:
            – TitleFull: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
              Type: main
ResultId 1